The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 17,539 | 696,000 | SH | SOLE | 696,000 | 0 | 0 | ||
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 14,169 | 1,437,028 | SH | SOLE | 1,437,028 | 0 | 0 | ||
| ALLENA PHARMACEUTICALS | COM | 018119107 | 4,629 | 3,330,373 | SH | SOLE | 3,330,373 | 0 | 0 | ||
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 27,257 | 2,571,450 | SH | SOLE | 2,571,450 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 19,389 | 899,700 | SH | SOLE | 899,700 | 0 | 0 | ||
| APTINYX INC | COM | 03836N103 | 9,570 | 3,190,079 | SH | SOLE | 3,190,079 | 0 | 0 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 305,003 | 10,542,790 | SH | SOLE | 10,542,790 | 0 | 0 | ||
| AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 5,226 | 578,104 | SH | SOLE | 578,104 | 0 | 0 | ||
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 4,948 | 1,296,743 | SH | SOLE | 1,296,743 | 0 | 0 | ||
| CARDIFF ONCOLOGY INC | COM | 14147L108 | 2,718 | 293,500 | SH | SOLE | 293,500 | 0 | 0 | ||
| EPIZYME INC | COM | 29428V104 | 6,440 | 739,369 | SH | SOLE | 739,369 | 0 | 0 | ||
| ESSA PHARMA INC | COM NEW | 29668H708 | 9,198 | 316,616 | SH | SOLE | 316,616 | 0 | 0 | ||
| FRAZIER LIFESCIENCES ACQU CO | UNIT 12/09/2025 | G3710A121 | 15,250 | 1,501,000 | SH | SOLE | 1,501,000 | 0 | 0 | ||
| FREELINE THERAPEUTICS HLDGS | SPONSORED ADS | 35655L107 | 6,765 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| GALERA THERAPEUTICS INC | COM | 36338D108 | 2,126 | 241,000 | SH | SOLE | 241,000 | 0 | 0 | ||
| GRITSTONE ONCOLOGY INC | COM | 39868T105 | 9,721 | 1,030,878 | SH | SOLE | 1,030,878 | 0 | 0 | ||
| IMMUNOVANT INC | COM | 45258J102 | 8,148 | 508,000 | SH | SOLE | 508,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 41,570 | 1,312,999 | SH | SOLE | 1,312,999 | 0 | 0 | ||
| ITERUM THERAPEUTICS PLC | SHS | G6333L101 | 2,169 | 1,538,316 | SH | SOLE | 1,538,316 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 15,725 | 2,544,500 | SH | SOLE | 2,544,500 | 0 | 0 | ||
| KRYSTAL BIOTECH INC | COM | 501147102 | 68,951 | 895,000 | SH | SOLE | 895,000 | 0 | 0 | ||
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | 70,696 | 3,566,912 | SH | SOLE | 3,566,912 | 0 | 0 | ||
| MOLECULAR TEMPLATES INC | COM | 608550109 | 17,340 | 1,374,047 | SH | SOLE | 1,374,047 | 0 | 0 | ||
| NABRIVA THERAPEUTICS PLC | SHS | G63637113 | 707 | 425,650 | SH | SOLE | 425,650 | 0 | 0 | ||
| PASSAGE BIO INC | COM | 702712100 | 87,561 | 5,009,219 | SH | SOLE | 5,009,219 | 0 | 0 | ||
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 218,878 | 5,827,415 | SH | SOLE | 5,827,415 | 0 | 0 | ||
| REGENXBIO INC | COM | 75901B107 | 12,005 | 351,954 | SH | SOLE | 351,954 | 0 | 0 | ||
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | 7,903 | 156,000 | SH | SOLE | 156,000 | 0 | 0 | ||
| SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 3,494 | 202,803 | SH | SOLE | 202,803 | 0 | 0 | ||
| SUTRO BIOPHARMA INC | COM | 869367102 | 22,792 | 1,001,421 | SH | SOLE | 1,001,421 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 32,088 | 1,435,045 | SH | SOLE | 1,435,045 | 0 | 0 | ||
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 61,790 | 1,917,157 | SH | SOLE | 1,917,157 | 0 | 0 | ||
| TRANSLATE BIO INC | COM | 89374L104 | 35,994 | 2,182,789 | SH | SOLE | 2,182,789 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 33,419 | 3,123,107 | SH | SOLE | 3,123,107 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | 45,614 | 2,309,554 | SH | SOLE | 2,309,554 | 0 | 0 | ||